Shares of Genscript Biotech Co. (OTCMKTS:GNNSF – Get Free Report) dropped 20% on Thursday . The company traded as low as C$1.24 and last traded at C$1.24. Approximately 500 shares traded hands during trading, a decline of 94% from the average daily volume of 8,000 shares. The stock had previously closed at C$1.55.
Genscript Biotech Stock Performance
The business has a 50-day moving average of C$1.31 and a two-hundred day moving average of C$1.41.
Genscript Biotech Company Profile
Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, the People's Republic of China, Japan, the other Asia Pacific regions, and internationally. The company operates through four segments: Life Science Services and Products; Biologics Development Services; Industrial Synthetic Biology Products; and Cell Therapy.
Read More
- Five stocks we like better than Genscript Biotech
- What Are Dividends? Buy the Best Dividend Stocks
- Roblox’s Big Dip: A Chance to Get in on the Vaunted Gaming Stock?
- Canada Bond Market Holiday: How to Invest and Trade
- 3 Dividend ETFs to Capitalize on the Slide in Chip Stocks
- What Are Earnings Reports?
- Is Chevron Stock Primed for Growth After Profit-Boosting News?
Receive News & Ratings for Genscript Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genscript Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
